Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 18 of 20
Efficacy of Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)
NCT00537641
Using Multimedia Technologies to Disseminate an HIV Prevention
NCT01863537
A Parent-Based Intervention to Reduce Sexual Risk Behavior in Adolescents
NCT00461487
Sunitinib in Certain Subtypes of Soft Tissue Sarcomas
NCT00859456
The Pharmacokinetics of Opioids and Sedative/Hypnotics During Selective Cerebral Perfusion
NCT00494598
Effect of Raised CBF During CEA on Cognition in DM Patients
NCT00597545
Adult Growth Hormone Deficiency and Cardiovascular Risk
NCT00720902
Sensitivity and Specificity of NGAL in an Emergency Room Population
NCT00786708
Bariatric Surgery for Morbid Obesity
NCT00675558
Effects of Sandostatin LAR® in Acromegaly
NCT01424241
Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease
NCT01137955
Body Composition & REE Responses to Bariatric Surgery
NCT00682058
A Randomized Trial of Unruptured Brain AVMs
NCT00389181
General Surgery Training Outcomes Project
NCT00461214
Fundic Gland Polyps and Proton Pump Inhibitor (PPI) Drugs
NCT01130363
Role of B2 Adrenergic Receptors in Labor Pain
NCT00385294
Written Asthma Actions Plans Versus No Written Instructions In Specialty Care
NCT00149461
PET Scan Imaging of Beta Cell Mass
NCT00771576
Race, Ethnicity, and Diffuse Parenchymal Lung Disease
NCT00453713
Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis
NCT00355576
Obesity, Oral Contraception, and Ovarian Suppression
NCT00827632
Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer
NCT00996502
Framing and Decision Making in Neonatology
NCT01421238
Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver
NCT01146808
Single-Breath Measurement Underestimates Ventilatory Volume According to Emphysema Severity
NCT00528944
Operating Room Outcomes After Resident Training on a Virtual Reality Simulator
NCT00459472
Nicotine Patch as an Analgesic Adjuvant After Surgery
NCT00440830
Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation
NCT00297830
HIV/STI Prevention for Drug-Involved Couples
NCT01285349
Primary Hyperparathyroidism: Non-classical Manifestations
NCT00432939
Neuroprotection With Statin Therapy for Acute Recovery Trial (Neu-START)
NCT00243880
Capecitabine and Temozolomide for Neuroendocrine Cancers
NCT00869050
Alimta Plus Gemcitabine for Advanced Sarcoma
NCT00860015
The Effect of Cinnamon Extract on Insulin Resistance Parameters in Polycystic Ovary Syndrome: A Pilot Study
NCT00331279
Efficacy and Safety Study of Tazarotene (Tazorac) for the Treatment of Brittle Nails
NCT00648986
Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer
NCT01378091
Coronary Heart Disease Incidence: Depression & Inflammation Risk
NCT00241774
GTX Regimen for Biliary Cancers
NCT00868998
Levels of Inflammatory Markers in the Treatment of Stroke-An SPS3 Ancillary Study
NCT00579306
Intravenous Immunoglobulin (IVIG) in Lung Transplantation
NCT00115778
Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar
NCT00869258
Acupuncture for Aromatase Inhibitor Induced Joint Pain
NCT00826397
Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users
NCT00447798
Clinical Study of Spinal Muscular Atrophy
NCT00443066
Clinical Trial of High Dose CoQ10 in ALS
NCT00243932
Changes in Insulin Sensitivity After Weight Loss
NCT00627484
The Stroke Warning Information and Faster Treatment Study (SWIFT)
NCT00415389
COPES Phase I Randomized Controlled Trial of Treatment For Distress in Heart Disease Patients
NCT00158054
Evaluating the Effectiveness of a Family Heart Health Educational Program (The FIT-Heart Study)
NCT00728637
Drug Abuse Prevention Among Girls Through a Mother-Daughter Intervention
NCT01236248
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Columbia University pipeline card: 958 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.